Soumya Swaminathan : No data to show double mutant variant is resistant to vaccination

There is currently no data available to show that the double coronavirus is resistant to vaccines, said Soumya Swaminathan, Chief Scientist of the World Health Organization (WHO), on May 10.

Swaminathan’s remarks come a day after parts of the Indian media reported that the double mutant could resist available vaccines.

Explaining his point, the WHO chief executive told CNBC TV-18 that “there is no data” showing that the B.1.617 type of coronavirus is able to avoid antibodies provided by vaccines.

“All available drugs reduce the risk of infection,” Swaminathan told a news channel, adding that even if a person has a COVID-19 contract after vaccination, infection is mild in most cases.

Asked if these two changes had driven the second wave of the Indian epidemic, Swaminathan said the interim data raises the role of B.1.617 in a sharp case. However, “there is not enough data” to completely stop the link.

“At the moment, it seems to be highly contagious, causing many diseases – but we don’t have enough information. We are looking forward to that data from India,” he said.

Soumya Swaminathan : No data to show double mutant variant is resistant to vaccination
Soumya Swaminathan : No data to show double mutant variant is resistant to vaccination

The WHO scientist also avoided predicting when the second wave in India could be detected. The country, which started out with an increase in “now it will move across the plains”, will also increase other provinces, he said.

On vaccination, Swaminathan said he supported India’s need for patents.

“Raising patent-related restrictions is important. Although It is a first step, but it is not enough. Vaccines are complex and difficult to perform compared to simple drugs,” he said, adding that technology transfer is equally important.

“Vaccines take a long time to develop. That is why in addition to patents we need the transfer of technology. That is the only way to raise the standard. It should be done in a transparent manner.

Notably, COVAX is a initiative led by the WHO and Gavi vaccination coalition to provide anti-COVID jabs to low-income countries.

Swaminathan also told CNBC TV-18 that countries with a large population should not lower their vigilance.

Even if 60 percent of vaccines are vaccinated, about 40 percent of people are still at risk of infection, he explains.

In India’s vaccination campaign, Swaminathan said the country should be commended for initiating vaccinations with key groups – health workers and other key workers.

However, a WHO senior scientist added that “countries need to have a forecast for vaccine delivery”.

Nearly 150 countries around the world have already started applying the vaccines in their fight against COVID-19. While the approved vaccines have also shown clinical efficacy, the data from continuous milling machines also show real world performance, Swaminathan also added saying that more than 90 percent of the world’s effectiveness has been seen in Israel – where more than half the population has been vaccinated.

About Staff reporter

Check Also

The Quantity of Covid Beds in Kolkata Hospitals Would Be Reduced

As the third wave of illnesses fades quickly, several hospitals expect to reduce the number of covid beds to the lowest level since the epidemic began in 2020.

Leave a Reply

Your email address will not be published. Required fields are marked *